Local biotechnology company, BioMedomics, received a $750,000 Phase II Small Business Innovation Research (SBIR) contract from the National Institutes of Health. The company was previously awarded a $25,000 North Carolina Biotechnology Center loan, and a $100,000 Phase I SBIR grant. BioMedomics will use the funds to demonstrate the scientific merit of its medical diagnostic technologies which include: reagents, assay instruments and data analysis tools targeting point-of-care personalized testing for specific disease biomarkers.
BioMedomics has been a member of CED since 2007. In addition to presenting at CED's Opportunity 2007 conference, company co-founder Frank Wang Ph.D., is a regular attendee of CED programs and events.